Atlas Trials

Monitoring of Piperacillin-Tazobactam and Meropenem Plasmatic Levels in Critical Patients

Clinical trial NCT04257838 · UNKNOWN

Trial details

NCT number
NCT04257838
Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Status
UNKNOWN
Study type
OBSERVATIONAL
SepsisSeptic Shock
Start date
2020-02-15
Primary completion
2020-12-15
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.